Health Economics in HIV Disease Mike YouleP. TruemanK. Simpson Review Article 27 November 2012 Pages: 1 - 12
Lamivudine Reduces Healthcare Resource Use when Added to Zidovudine-Containing Regimens in Patients with HIV Infection L. LaceyM.J. Gill Original Research Article 27 November 2012 Pages: 13 - 22
A Prospective Cost-Consequence Analysis of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens for HIV Infection in the US L. LaceyJ. MauskopfW. Sawyer Original Research Article 27 November 2012 Pages: 23 - 37
A Prospective Evaluation of the Cost Effectiveness of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens in HIV Infection L. LaceyM. YouleM. Behrens Original Research Article 27 November 2012 Pages: 39 - 53
An Evaluation of the Cost Effectiveness of Adding Lamivudine to Zidovudine-Containing Regimens in HIV Infection L. LaceyP.K. HopkinsonM.J. Gill Original Research Article 27 November 2012 Pages: 55 - 66
Quality of Life and Treatment Satisfaction After the Addition of Lamivudine or Lamivudine plus Loviride to Zidovudine-Containing Regimens in Treatment-Experienced Patients with HIV Infection M.L. ChattertonJ. Scott-LennoxJ. Scott Original Research Article 27 November 2012 Pages: 67 - 74